Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry - Hopkin, Robert J.; Cabrera, Gustavo; Charrow, Joel; Lemay, Roberta; Martins, Ana Maria; Mauer, Michael; Ortiz, Alberto; Patel, Manesh R.; Sims, Katherine; Waldek, Stephen; Warnock, David G.; Wilcox, William R. (Molecular Genetics And Metabolism, 2016)